Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Metzner

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Seminars in Thrombosis and Hemostasis|January 1, 1996
Therapeutic factor XIII preparations and perspectives for recombinant factor XIIIH E Karges, H J Metzner
FEBS Letters|March 27, 1998
Two non-proline cis peptide bonds may be important for factor XIII functionM S Weiss, H J Metzner, R Hilgenfeld
Thrombosis and Haemostasis|November 2, 2013
Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albuminH J Metzner, S W Pipe, T Weimer, et al.
FEBS Letters|June 4, 1990
Crystallization of blood coagulation factor XIII by an automated procedureR Hilgenfeld, A Liesum, R Storm, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysisH J Metzner, P Hermentin, T Cuesta-Linker, et al.
The Journal of Experimental Medicine|May 4, 1999
Effect of factor XIII on endothelial barrier functionT Noll, G Wozniak, K McCarson, et al.
Journal of Thrombosis and Haemostasis : JTH|December 24, 2017
International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratoriesK St Ledger, A Feussner, U Kalina, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Seminars in Thrombosis and Hemostasis|January 1, 1996
Therapeutic factor XIII preparations and perspectives for recombinant factor XIIIH E Karges, H J Metzner
FEBS Letters|March 27, 1998
Two non-proline cis peptide bonds may be important for factor XIII functionM S Weiss, H J Metzner, R Hilgenfeld
Thrombosis and Haemostasis|November 2, 2013
Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albuminH J Metzner, S W Pipe, T Weimer, et al.
FEBS Letters|June 4, 1990
Crystallization of blood coagulation factor XIII by an automated procedureR Hilgenfeld, A Liesum, R Storm, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysisH J Metzner, P Hermentin, T Cuesta-Linker, et al.
The Journal of Experimental Medicine|May 4, 1999
Effect of factor XIII on endothelial barrier functionT Noll, G Wozniak, K McCarson, et al.
Journal of Thrombosis and Haemostasis : JTH|December 24, 2017
International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratoriesK St Ledger, A Feussner, U Kalina, et al.
Pageof 1